These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 81506)

  • 21. Interactions between calcium channel blockers and non-cardiovascular drugs: interactions with anticancer drugs.
    Baeyens JM
    Pharmacol Toxicol; 1988 Jul; 63(1):1-7. PubMed ID: 3041398
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacokinetics of anticancer drugs in children.
    Evans WE; Crom WR; Sinkule JA; Yee GC; Stewart CF; Hutson PR
    Drug Metab Rev; 1983; 14(5):847-86. PubMed ID: 6197269
    [No Abstract]   [Full Text] [Related]  

  • 23. Microbial hydroxylation of quadrone to 8a-hydroxyquadrone.
    Goswami A; Beale JM; Chapman RL; Miller DW; Rosazza JP
    J Nat Prod; 1987; 50(1):49-54. PubMed ID: 3598598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vinca alkaloids. XXXII. Microbiological conversions of vindoline, a major alkaloid from Vinca rosea L.
    Neuss N; Fukuda DS; Mallett GE; Brannon DR; Huckstep LL
    Helv Chim Acta; 1973 Jul; 56(7):2418-26. PubMed ID: 4761279
    [No Abstract]   [Full Text] [Related]  

  • 25. [Search for new antitumor antibiotics in the bleomycin group].
    Gauze GF; Maksimova TS; Ol'khovatova OL
    Antibiotiki; 1978 Aug; 23(8):675-6. PubMed ID: 80152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Redox transformations of quinone antitumor drugs in liver microsomes.
    Rumyantseva GV; Weiner LM
    FEBS Lett; 1988 Jul; 234(2):459-63. PubMed ID: 2839377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transport of glutathione conjugates and chemotherapeutic drugs by RLIP76 (RALBP1): a novel link between G-protein and tyrosine kinase signaling and drug resistance.
    Awasthi S; Singhal SS; Sharma R; Zimniak P; Awasthi YC
    Int J Cancer; 2003 Sep; 106(5):635-46. PubMed ID: 12866021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tallysomycin, a new antitumor antibiotic complex related to bleomycin. I. Production, isolation and properties.
    Kawaguchi H; Tsukiura H; Tomita K; Konishi M; Saito K
    J Antibiot (Tokyo); 1977 Oct; 30(10):779-88. PubMed ID: 591443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anthracycline metabolites from Streptomyces violaceus A262. I. Isolation of antibiotic-blocked mutants from Streptomyces violaceus A262.
    Johdo O; Ishikura T; Yoshimoto A; Takeuchi T
    J Antibiot (Tokyo); 1991 Oct; 44(10):1110-20. PubMed ID: 1955394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microbial transformations of natural antitumor agents: O-demethylation of vindoline by Sepedonium chrysospermum.
    Wu GS; Nabih T; Youel L; Peczynska-Czoch W; Rosazza JP
    Antimicrob Agents Chemother; 1978 Oct; 14(4):601-4. PubMed ID: 568911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacokinetics of the antitumor antibiotic bleomycetin in cancer patients given the preparation by different methods].
    Smolianskaia AZ; Spitsyna TA; Manziuk LV
    Antibiotiki; 1984 Aug; 29(8):616-9. PubMed ID: 6207770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The antibiotic galtamycin. Its fermentation, isolation, physicochemical and biological properties].
    Korobkova TP; Singal EM; Ivanitskaia LP; Kudinova MK; Karbyshev VD
    Antibiot Med Biotekhnol; 1986 Jun; 31(6):428-31. PubMed ID: 3461745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potent antitumor antibiotic complex: PD 114,759, PD 115,028, PD 119,707, and PD 119,193.
    Tunac JB; Graham BD; Mamber SW; Dobson WE; Lenzini MD
    J Antibiot (Tokyo); 1985 Oct; 38(10):1337-43. PubMed ID: 3840793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vince alkaloids XXXIV). Preparation of des-Na-methyl-vindoline by microbiological conversion of vindoline, a major alkaloid from Vinca rosea L.
    Neuss N; Fukuda DS; Brannon DR; Huckstep LL
    Helv Chim Acta; 1974; 57(6):1891-3. PubMed ID: 4465346
    [No Abstract]   [Full Text] [Related]  

  • 35. 167-A, a new antibiotic produced by a mutant of an inactive wild strain of Amycolata autotrophica.
    Malkina ND; Dudnik YV; Lysenkova LN; Lazhko EI; Galatenko OA; Katrukha GS
    J Antibiot (Tokyo); 1994 Mar; 47(3):342-8. PubMed ID: 8175487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An introduction to the metabolic determinants of anthracycline cardiotoxicity.
    Menna P; Recalcati S; Cairo G; Minotti G
    Cardiovasc Toxicol; 2007; 7(2):80-5. PubMed ID: 17652809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbial models of mammalian metabolism. O-Dealkylation of 10,11-dimethoxyaporphine.
    Rosazza JP; Stocklinski AW; Gustafson MA; Adrian J; Smith RV
    J Med Chem; 1975 Aug; 18(8):791-4. PubMed ID: 1159695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production and biological activity of marcellomycin, an antitumor anthracycline antibiotic, and taxonomy of the producing organism.
    Bush JA; Bradner WT; Tomita K
    J Antibiot (Tokyo); 1982 Sep; 35(9):1174-83. PubMed ID: 6754675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uptake and metabolism of vinca alkaloids by freshly isolated human hepatocytes in suspension.
    Zhou XJ; Placidi M; Rahmani R
    Anticancer Res; 1994; 14(3A):1017-22. PubMed ID: 8074443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies on antitumor antibiotic 1588--IV. Metabolism and toxicity studies].
    Yang GZ
    Zhonghua Zhong Liu Za Zhi; 1983 Jan; 5(1):5-7. PubMed ID: 6189686
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.